Novo Nordisk B A/S

Novo Nordisk is a leading global healthcare company that specializes in the development, production, and distribution of innovative pharmaceutical products and medical devices. With a strong focus on diabetes care, the company is dedicated to improving the lives of individuals living with chronic diseases. Novo Nordisk's extensive portfolio includes a range of insulin products, GLP-1 analogs, and other diabetes treatments, as well as products for obesity, hemophilia, and growth hormone disorders. Operating in over 80 countries and employing more than 45,000 people worldwide, Novo Nordisk is committed to sustainability and social responsibility. The company strives to minimize its environmental impact and improve access to healthcare for underserved populations.